Better Buy: Gilead Sciences, Inc. vs. Amgen
Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD) are central figures within the biotech landscape. However, these two titans of the industry are both in the process of refreshing their product portfolios at the moment.
This is therefore an opportune time to consider which of these top biotech stocks is the better long-term buy right now. So let's dig in to reveal which of these biotech giants is more deserving of your hard-earned capital.
Image source: Getty Images.
Source: Fool.com
Amgen Inc. Stock
€307.05
-0.390%
The stock is an absolute favorite of our community with 25 Buy predictions and no Sell predictions.
On the other hand, the target price of 304 € is below the current price of 307.05 € for Amgen Inc., so the potential is actually -0.99%.
